BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 17398018)

  • 61. Comparison of tumor volumes as determined by pathologic examination and FDG-PET/CT images of non-small-cell lung cancer: a pilot study.
    Yu J; Li X; Xing L; Mu D; Fu Z; Sun X; Sun X; Yang G; Zhang B; Sun X; Ling CC
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1468-74. PubMed ID: 19464822
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
    Cardoso M; Min M; Jameson M; Tang S; Rumley C; Fowler A; Estall V; Pogson E; Holloway L; Forstner D
    J Med Imaging Radiat Oncol; 2019 Jun; 63(3):399-407. PubMed ID: 30816646
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer.
    Nestle U; Schaefer-Schuler A; Kremp S; Groeschel A; Hellwig D; Rübe C; Kirsch CM
    Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):453-62. PubMed ID: 17058078
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion.
    Caldwell CB; Mah K; Ung YC; Danjoux CE; Balogh JM; Ganguli SN; Ehrlich LE
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):923-31. PubMed ID: 11704312
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tumor volume delineation in head and neck cancer with 18-fluor-fluorodeoxiglucose positron emission tomography: adaptive thresholding method applied to primary tumors and metastatic lymph nodes.
    Perez-Romasanta LA; Bellon-Guardia M; Torres-Donaire J; Lozano-Martin E; Sanz-Martin M; Velasco-Jimenez J
    Clin Transl Oncol; 2013 Apr; 15(4):283-93. PubMed ID: 22865325
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer?
    Fox JL; Rengan R; O'Meara W; Yorke E; Erdi Y; Nehmeh S; Leibel SA; Rosenzweig KE
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):70-5. PubMed ID: 15850904
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes.
    Ford EC; Kinahan PE; Hanlon L; Alessio A; Rajendran J; Schwartz DL; Phillips M
    Med Phys; 2006 Nov; 33(11):4280-8. PubMed ID: 17153406
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of primary tumour volumes delineated on four-dimensional computed tomography maximum intensity projection and (18) F-fluorodeoxyglucose positron emission tomography computed tomography images of non-small cell lung cancer.
    Duan Y; Li J; Zhang Y; Wang W; Sun X; Fan T; Shao Q; Xu M; Guo Y; Shang D
    J Med Imaging Radiat Oncol; 2015 Oct; 59(5):623-30. PubMed ID: 25754243
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.
    Gondi V; Bradley K; Mehta M; Howard A; Khuntia D; Ritter M; Tomé W
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):187-95. PubMed ID: 17189070
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer.
    Guido A; Fuccio L; Rombi B; Castellucci P; Cecconi A; Bunkheila F; Fuccio C; Spezi E; Angelini AL; Barbieri E
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):759-63. PubMed ID: 18834671
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Improving observer variability in target delineation for gastro-oesophageal cancer--the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.
    Vesprini D; Ung Y; Dinniwell R; Breen S; Cheung F; Grabarz D; Kamra J; Mah K; Mansouri A; Pond G; Brock K; Darling G; Knox J; Haider M; Wong RK
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):631-8. PubMed ID: 18755578
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Segmentation of PET volumes by iterative image thresholding.
    Jentzen W; Freudenberg L; Eising EG; Heinze M; Brandau W; Bockisch A
    J Nucl Med; 2007 Jan; 48(1):108-14. PubMed ID: 17204706
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differences in gross tumor volumes for pancreatic cancer: a comparison of ungated positron emission tomography and contrast-enhanced four-dimensional computed tomography.
    Takahashi S; Anada M; Kinoshita T; Nishide T; Shibata T
    Jpn J Radiol; 2019 Apr; 37(4):336-340. PubMed ID: 30680663
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer.
    Wang H; Vees H; Miralbell R; Wissmeyer M; Steiner C; Ratib O; Senthamizhchelvan S; Zaidi H
    Radiother Oncol; 2009 Nov; 93(2):220-5. PubMed ID: 19767115
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 18F-FDG-PET-based tumor delineation in cervical cancer: threshold contouring and lesion volumes.
    Erlich F; Camisão C; Nogueira-Rodrigues A; Altino S; Ferreira CG; Mamede M
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):162-6. PubMed ID: 22831777
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features.
    van Loon J; Siedschlag C; Stroom J; Blauwgeers H; van Suylen RJ; Knegjens J; Rossi M; van Baardwijk A; Boersma L; Klomp H; Vogel W; Burgers S; Gilhuijs K
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):448-56. PubMed ID: 20971575
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cone-beam CT-based delineation of stereotactic lung targets: the influence of image modality and target size on interobserver variability.
    Altorjai G; Fotina I; Lütgendorf-Caucig C; Stock M; Pötter R; Georg D; Dieckmann K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e265-72. PubMed ID: 21620581
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Defining a radiotherapy target with positron emission tomography.
    Black QC; Grills IS; Kestin LL; Wong CY; Wong JW; Martinez AA; Yan D
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1272-82. PubMed ID: 15519800
    [TBL] [Abstract][Full Text] [Related]  

  • 79. (18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy.
    Sura S; Greco C; Gelblum D; Yorke ED; Jackson A; Rosenzweig KE
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1397-402. PubMed ID: 18374225
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning.
    Hong TS; Killoran JH; Mamede M; Mamon HJ
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1612-8. PubMed ID: 19028285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.